StockData
OraSure Technologies Inc logo

OraSure Technologies Inc (OSUR) stock

OSURNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q/A on Nov 12, 2026Score 11/3037% below fair value
$3.51−0.09 (-2.50%)

Close on Nov 17, 2026Market cap $242.08MP/E –Yield –

Earnings

OraSure Technologies's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 24, 2027
Q4 FY2026 · estimated, after the close
Revenue, Q3 FY2026
$30.90M
+14.0% on a year earlier
Non-GAAP Diluted EPS, Q3 FY2026
-$0.15
-$0.13 a year earlier
Latest guidance
Issued
Nov 9, 2026 · 2 items

Quarterly results

Revenue and earnings per share from each of OraSure Technologies's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Dec 31, 2026Feb 24, 2027Expected–––––
Q3 FY2026ended Sep 30, 2026Nov 9, 2026after the close$30.90M+14.0%-$0.19-$0.15Release
Q2 FY2026ended Jun 30, 2026Aug 5, 2026after the close$30.60M-1.9%$0.09-$0.20Release
Q1 FY2026ended Mar 31, 2026May 6, 2026after the close$27.90M-6.7%––Release
Q4 FY2025ended Dec 31, 2025Feb 25, 2026after the close$26.80M-28.3%-$0.27-$0.19Release
Q3 FY2025ended Sep 30, 2025Nov 5, 2025after the close$27.10M-32.1%-$0.19-$0.13Release
Q2 FY2025ended Jun 30, 2025Aug 5, 2025after the close$31.20M-42.5%––Release
Q1 FY2025ended Mar 31, 2025May 7, 2025after the close$29.90M-44.7%-$0.21-$0.18Release
Q4 FY2024ended Dec 31, 2024Feb 25, 2025after the close$37.40M-50.7%-$0.14-$0.06Release
Q3 FY2024ended Sep 30, 2024Nov 6, 2024after the close$39.90M-55.3%-$0.06-$0.01Release
Q2 FY2024ended Jun 30, 2024Aug 6, 2024after the close$54.30M-36.4%-$0.01$0.07Release
Q1 FY2024ended Mar 31, 2024May 8, 2024after the close$54.10M-65.1%-$0.05$0.04Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

OraSure Technologies's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
total revenuesQ4 FY2026$30.00M – $32.00M–NewNov 9, 2026
year-over-year growth rateFY2026+4.7%–NewNov 9, 2026

Guidance vs results

The last range OraSure Technologies gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
Q3 FY2026Revenue$29.50M – $32.50M$30.90MWithin range
Q2 FY2026Revenue$27.00M – $30.00M$30.60MAbove range
Q1 FY2026Revenue$26.00M – $29.00M$27.90MWithin range
Q4 FY2025Revenue$25.00M – $28.00M$26.80MWithin range
Q3 FY2025Revenue$27.00M – $30.00M$27.10MWithin range
Q2 FY2025Revenue$28.50M – $32.50M$31.20MWithin range
Q1 FY2025Revenue$27.50M – $31.50M$29.90MWithin range
Q4 FY2024Revenue$36.00M – $38.00M$37.40MWithin range
Q3 FY2024Revenue$37.00M – $41.00M$39.90MWithin range
Q2 FY2024Revenue$50.00M – $55.00M$54.30MWithin range
Q1 FY2024Revenue$50.00M – $54.00M$54.10MAbove range
Q4 FY2023Revenue$71.00M – $76.00M$75.90MWithin range

Guidance history

Every forecast OraSure Technologies put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 9, 2026total revenuesQ4 FY2026$30.00M – $32.00MNew
Nov 9, 2026year-over-year growth rateFY2026+4.7%New
Aug 5, 2026total revenuesQ3 FY2026$29.50M – $32.50MNew
May 6, 2026Total revenuesQ2 FY2026$27.00M – $30.00MNew
Feb 25, 2026Total revenuesQ1 FY2026$26.00M – $29.00MNew
Nov 5, 2025Total revenuesQ4 FY2025$25.00M – $28.00MNew
Aug 5, 2025Total revenuesQ3 FY2025$27.00M – $30.00MNew
May 7, 2025Core revenuesQ2 FY2025$28.00M – $32.00MNew
May 7, 2025COVID-19 and Risk Assessment testing revenuesQ2 FY2025$500.00KLowered
May 7, 2025revenuesQ2 FY2025$28.50M – $32.50MNew
Feb 25, 2025revenuesQ1 FY2025$27.50M – $31.50MNew
Feb 25, 2025Core revenuesQ1 FY2025$27.00M – $31.00MLowered
Feb 25, 2025COVID-19 revenuesQ1 FY2025$500.00KLowered
Nov 6, 2024revenuesQ4 FY2024$36.00M – $38.00MNew
Nov 6, 2024Core revenuesQ4 FY2024$35.00M – $37.00MLowered
Nov 6, 2024Risk Assessment testing revenuesQ4 FY2024$1.00M – $2.00MLowered
Nov 6, 2024COVID-19 revenuesQ4 FY2024$1.00MLowered
Aug 6, 2024revenuesQ3 FY2024$37.00M – $41.00MNew
May 8, 2024revenueQ2 FY2024$50.00M – $55.00MNew
Feb 27, 2024core revenueQ1 FY2024$29.00M – $31.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases OraSure Technologies filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Results
  4. Results
  5. Update
  6. Update
  7. Results
  8. Results
  9. Update
  10. Results
  11. Results
  12. Results
  13. Results
  14. News
  15. Results

See a number that looks wrong?